Exelixis
EXEL
#1619
Rank
A$19.36 B
Marketcap
A$77.02
Share price
0.68%
Change (1 day)
15.42%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company